SCHEMBL3780116

SCHEMBL3780116

CCN(CC)c1ccc2c(=O)[nH][nH]c(=O)c2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.68
TDP1 Q9NUW8 4/20 0.68
ALDH1A1 P00352 9/20 0.49
L3MBTL1 Q9Y468 5/20 0.49
MEN1 O00255 4/20 0.49
MAPT P10636 4/20 0.49
KMT2A Q03164 4/20 0.49
HPGD P15428 3/20 0.49
HSD17B10 Q99714 3/20 0.49
MAPK1 P28482 2/20 0.49
AR P10275 3/20 0.48
GLA P06280 5/20 0.47
CYP3A4 P08684 3/20 0.47
ATM Q13315 3/20 0.47
CASP1 P29466 2/20 0.47
CASP7 P55210 2/20 0.47
IGLV6-57 P01721 1/20 0.47
HIF1A Q16665 1/20 0.47
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12909466 0.90 KDM4E (0.62) KDM4ETDP1ALDH1A1L3MBTL1MEN1
SCHEMBL3075296 0.87 KDM4E (0.80) KDM4ETDP1ALDH1A1L3MBTL1MEN1
SCHEMBL29421600 0.87 KDM4E (0.80) KDM4ETDP1ALDH1A1L3MBTL1MEN1
SCHEMBL5567066 0.87 KDM4E (0.75) KDM4ETDP1ALDH1A1L3MBTL1MEN1
SCHEMBL12208991 0.86 KDM4E (0.78) KDM4ETDP1ALDH1A1L3MBTL1MEN1
SCHEMBL14321770 0.83 KDM4E (0.97) KDM4ETDP1ALDH1A1L3MBTL1MEN1
SCHEMBL29394268 0.83 KDM4E (0.97) KDM4ETDP1ALDH1A1L3MBTL1MEN1
SCHEMBL437558 0.83 KDM4E (0.97) KDM4ETDP1ALDH1A1L3MBTL1MEN1
SCHEMBL29421583 0.82 KDM4E (1.00) KDM4ETDP1ALDH1A1L3MBTL1MEN1
SCHEMBL436768 0.82 KDM4E (1.00) KDM4ETDP1ALDH1A1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1497664-B1 METHOD OF DETECTING AND LOCATING TRACES OF BLOOD AND A COMPOUND FOR DETECTING TRACES OF BLOOD ROC IMP (MC) 2007-03-21 EP claimed
US-20050176082-A1 Method of detecting and locating traces of blood and a compound for detecting traces of blood LEFEBVRE-DESPEAUX, JEAN-MARC (MC) 2005-08-11 US claimed
EP-1497664-A2 METHOD OF DETECTING AND LOCATING TRACES OF BLOOD AND A COMPOUND FOR DETECTING TRACES OF BLOOD Roc Import (MC) 2005-01-19 EP claimed
WO-2003091687-A2 METHOD AND COMPOUND FOR DETECTING TRACES OF BLOOD ROC IMPORT (MC) 2003-11-06 WO claimed
US-8148173-B2 Polymerizable chemiluminescent compounds UNIVERSITY OF ST. THOMAS (US) 2012-04-03 US disclosed
US-8148173-B2 Polymerizable chemiluminescent compounds UNIVERSITY OF ST. THOMAS (US) 2012-04-03 US disclosed
US-7662639-B2 Composition, kit and method of detecting and locating traces of blood ROC IMPORT (MC) 2010-02-16 US disclosed
US-20080233601-A1 POLYMERIZABLE CHEMILUMINESCENT COMPOUNDS UNIVERSITY OF ST. THOMAS 2008-09-25 US disclosed
US-20080233601-A1 POLYMERIZABLE CHEMILUMINESCENT COMPOUNDS UNIVERSITY OF ST. THOMAS 2008-09-25 US disclosed
EP-1497664-B1 METHOD OF DETECTING AND LOCATING TRACES OF BLOOD AND A COMPOUND FOR DETECTING TRACES OF BLOOD ROC IMP (MC) 2007-03-21 EP disclosed
US-20050176082-A1 Method of detecting and locating traces of blood and a compound for detecting traces of blood LEFEBVRE-DESPEAUX, JEAN-MARC (MC) 2005-08-11 US disclosed
CN-1646918-A Method of detecting and locating traces of blood and a compound for detecting traces of blood ROC IMP (MC) 2005-07-27 CN disclosed
EP-1497664-A2 METHOD OF DETECTING AND LOCATING TRACES OF BLOOD AND A COMPOUND FOR DETECTING TRACES OF BLOOD Roc Import (MC) 2005-01-19 EP disclosed
WO-2003091687-A2 METHOD AND COMPOUND FOR DETECTING TRACES OF BLOOD ROC IMPORT (MC) 2003-11-06 WO disclosed
WO-1987005941-A1 MICROCHEMILUMINESCENT ASSAY FOR DETECTION AND QUANTIFICATION OF OXIDATIVE INJURY TO CELLS MCLAS TECHNOLOGIES, INC. (US) 1987-10-08 WO disclosed
EP-0175577-A2 Microchemiluminescent assay system Kiel, Jonathan L (US) 1986-03-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080233601-A1 POLYMERIZABLE CHEMILUMINESCENT COMPOUNDS C9, C3AR1, C5 KDM4E 4366/4885TDP1 3226/4885ALDH1A1 549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.